Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Immutep LTD ADR buy Mori8

Start price
€2.62
20.09.16 / 50%
Target price
€3.60
27.09.16
Performance (%)
0.00%
End price
€2.62
27.09.16
Summary
This prediction ended on 27.09.16 with a price of €2.62. Mori8's BUY prediction for Immutep LTD ADR closed unchanged from the start price. Mori8 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Immutep LTD ADR -15.238% -15.238% -13.592% -40.268%
iShares Core DAX® -3.033% -0.013% 11.953% 15.609%
iShares Nasdaq 100 -3.554% -2.546% 30.128% 44.540%
iShares Nikkei 225® -3.938% 2.183% 11.741% 8.345%
iShares S&P 500 -1.517% -0.882% 25.752% 42.388%

Comments by Mori8 for this prediction

In the thread Immutep LTD ADR diskutieren
Prediction Buy
Perf. (%) 0.00%
Target price 3.600
Change
Ends at 27.09.16

Das Unternehmen konzentriert sich auf die Immuntherapie von Krebs-Forschung.

Brokers have set a twelve-month consensus target price of $5.00 for the company, according to Zacks.


Prediction Buy
Perf. (%) 0.00%
Target price 3.600
Change
Ends at 27.09.16

(Vom Mitglied beendet)